Cite
HARVARD Citation
Yoshida, C. et al. (2022). Tumor-associated CD163+ macrophage as a predictor of tumor spread through air spaces and with CD25+ lymphocyte as a prognostic factor in resected stage I lung adenocarcinoma. Lung cancer. pp. 34-40. [Online].